摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(benzimidazol-1-yl)-6-chloro-N-(5-methoxy-2-methylphenyl)pyrimidin-4-amine | 918870-35-6

中文名称
——
中文别名
——
英文名称
2-(benzimidazol-1-yl)-6-chloro-N-(5-methoxy-2-methylphenyl)pyrimidin-4-amine
英文别名
——
2-(benzimidazol-1-yl)-6-chloro-N-(5-methoxy-2-methylphenyl)pyrimidin-4-amine化学式
CAS
918870-35-6
化学式
C19H16ClN5O
mdl
——
分子量
365.822
InChiKey
FMAZGGUXSRCPNZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    597.3±60.0 °C(Predicted)
  • 密度:
    1.36±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.53
  • 重原子数:
    26.0
  • 可旋转键数:
    4.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    64.86
  • 氢给体数:
    1.0
  • 氢受体数:
    6.0

SDS

SDS:64cee3c91985a5f8b96857a3b5640991
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(benzimidazol-1-yl)-6-chloro-N-(5-methoxy-2-methylphenyl)pyrimidin-4-amine三溴化硼 作用下, 以 二氯甲烷 为溶剂, 以50%的产率得到3-(2-(1H-benzo[d]imidazol-1-yl)-6-chloropyrimidin-4-ylamino)-4-methylphenol
    参考文献:
    名称:
    The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck)
    摘要:
    This communication details the synthesis, biological activity, and binding mode of a novel class of 2-benzimidazole substituted pyrimidines. The most potent analogs disclosed showed low nanomolar activity for the inhibition of Lck kinase and a representative analog was co-crystallized with Hck (a structurally related member of the Src family kinases).
    DOI:
    10.1016/j.bmcl.2006.08.132
  • 作为产物:
    参考文献:
    名称:
    The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck)
    摘要:
    This communication details the synthesis, biological activity, and binding mode of a novel class of 2-benzimidazole substituted pyrimidines. The most potent analogs disclosed showed low nanomolar activity for the inhibition of Lck kinase and a representative analog was co-crystallized with Hck (a structurally related member of the Src family kinases).
    DOI:
    10.1016/j.bmcl.2006.08.132
点击查看最新优质反应信息

文献信息

  • The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck)
    作者:Mark Sabat、John C. VanRens、Matthew J. Laufersweiler、Todd A. Brugel、Jennifer Maier、Adam Golebiowski、Biswanath De、Vijayasurian Easwaran、Lily C. Hsieh、Richard L. Walter、Marlene J. Mekel、Artem Evdokimov、Michael J. Janusz
    DOI:10.1016/j.bmcl.2006.08.132
    日期:2006.12
    This communication details the synthesis, biological activity, and binding mode of a novel class of 2-benzimidazole substituted pyrimidines. The most potent analogs disclosed showed low nanomolar activity for the inhibition of Lck kinase and a representative analog was co-crystallized with Hck (a structurally related member of the Src family kinases).
查看更多